These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33680585)

  • 1. A Case of Gemcitabine-Induced Thrombotic Microangiopathy Treated With Ravulizumab in a Patient With Stage IV Pancreatic Cancer.
    MacDougall KN; Schwartz B; Harewood J; Bukhari Z; Neculiseanu E
    Cureus; 2021 Jan; 13(1):e13031. PubMed ID: 33680585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
    Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R
    BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney.
    Ryu H; Kang E; Park S; Park S; Lee K; Joo KW; Lee H
    Kidney Res Clin Pract; 2015 Dec; 34(4):237-40. PubMed ID: 26779428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report.
    Van den Eeckhaut L; Hannon H; Schurgers M; Monsaert E; Claes K
    J Gastrointest Oncol; 2022 Dec; 13(6):3314-3320. PubMed ID: 36636054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic Microangiopathy After Long-Lasting Treatment by Gemcitabine: Description, Evolution and Treatment of a Rare Case.
    Bertin L; Gauthier M; Boullenger F; Brocheriou I; Chevallier R; Mary F; Dhote R; Belenfant X
    J Med Cases; 2024 Oct; 15(10):272-277. PubMed ID: 39328805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer].
    Kashima H; Minami R; Ozawa T; Matsumoto A; Kimura Y; Takeda Y; Ueo T; Okano A; Kusumi F; Ohana M
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(3):259-266. PubMed ID: 35264490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: A case report.
    Lai-Tiong F; Duval Y; Krabansky F
    Oncol Lett; 2017 Mar; 13(3):1201-1203. PubMed ID: 28454234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine-Induced Thrombotic Microangiopathy in a Patient With Cholangiocarcinoma: An Atypical Case.
    Anil V; Alhujaily E; Grover D; Santos JP; Kanugula AK; Suleiman M; Singh S
    Cureus; 2024 Jun; 16(6):e63385. PubMed ID: 39070506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations.
    Murugapandian S; Bijin B; Mansour I; Daheshpour S; Pillai BG; Thajudeen B; Salahudeen AK
    Case Rep Nephrol Dial; 2015; 5(2):160-7. PubMed ID: 26266248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
    J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eculizumab therapy in gemcitabine-induced thrombotic microangiopathy in a renal transplant recipient.
    Martin K; Roberts V; Chong G; Goodman D; Hill P; Ierino F
    Oxf Med Case Reports; 2019 Jun; 2019(6):omz048. PubMed ID: 31214360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy.
    Sterner RC; Rose WN
    Hematol Rep; 2022 Apr; 14(2):119-125. PubMed ID: 35466182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
    Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic-uremic syndrome due to complement factor I mutation.
    Almalki AH; Sadagah LF; Qureshi M; Maghrabi H; Algain A; Alsaeed A
    World J Nephrol; 2017 Nov; 6(6):243-250. PubMed ID: 29226095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer.
    Hausberg M; Felten H; Pfeffer S
    Case Rep Oncol; 2019; 12(1):1-6. PubMed ID: 30792638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab.
    Raufi AG; Scott S; Darwish O; Harley K; Kahlon K; Desai S; Lu Y; Tran MH
    Hematol Rep; 2016 Sep; 8(3):6625. PubMed ID: 27781079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
    Mehmood T; Taylor M; Winters JL
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy and acute kidney injury following Sri Lankan
    Wijewickrama ES; Gooneratne LV; Gnanathasan A; Gawarammana I; Gunatilake M; Isbister GK
    Clin Toxicol (Phila); 2020 Oct; 58(10):997-1003. PubMed ID: 32067496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.